Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.43 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | STING1 | Q86WV6 | 7/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.40 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.40 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | HINT1 | P49773 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19981039 | 0.91 | TAS1R3 (0.46) | TAS1R3TAS1R1ALDH1A1STING1TAAR1 | |
| SCHEMBL15892164 | 0.91 | TAS1R3 (0.46) | TAS1R3TAS1R1ALDH1A1STING1TAAR1 | |
| SCHEMBL20215731 | 0.91 | TAS1R3 (0.46) | TAS1R3TAS1R1ALDH1A1STING1TAAR1 | |
| SCHEMBL15850632 | 0.91 | TAS1R3 (0.46) | TAS1R3TAS1R1ALDH1A1STING1TAAR1 | |
| SCHEMBL25496217 | 0.87 | KDM4E (0.47) | TAS1R3TAS1R1ALDH1A1STING1PDE3B | |
| SCHEMBL19880310 | 0.87 | KDM4E (0.47) | TAS1R3TAS1R1ALDH1A1STING1PDE3B | |
| SCHEMBL1936920 | 0.87 | KDM4E (0.47) | TAS1R3TAS1R1ALDH1A1STING1PDE3B | |
| SCHEMBL19509409 | 0.87 | KDM4E (0.47) | TAS1R3TAS1R1ALDH1A1STING1PDE3B | |
| SCHEMBL18954971 | 0.87 | KDM4E (0.47) | TAS1R3TAS1R1ALDH1A1STING1PDE3B | |
| SCHEMBL10457794 | 0.87 | KDM4E (0.47) | TAS1R3TAS1R1ALDH1A1STING1PDE3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8202983-B2 | Thiocarbon-protecting groups for RNA synthesis | AGILENT TECHNOLOGIES, INC. (US) | 2012-06-19 | — | — | US | disclosed |
| US-20090209479-A1 | THIOCARBON-PROTECTING GROUPS FOR RNA SYNTHESIS | AGILENT TECHNOLOGIES, INC. | 2009-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090209479-A1 | THIOCARBON-PROTECTING GROUPS FOR RNA SYNTHESIS | NSUN3, NSUN2, TRDMT1 | TAS1R3 1883/4885TAS1R1 2416/4885ALDH1A1 2446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.